Profile change history

What changed for Tesofensine?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Tesofensine identity.

11Total events
11Record additions
0Version changes
8Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 11 connected records →

Showing the latest 11 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT00006077

PeptideScanner retained ClinicalTrials.gov record NCT00006077 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
March 4, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00394667

PeptideScanner retained ClinicalTrials.gov record NCT00394667 at 2026-11-16T17:29:46.323Z. Its registry update date was 2013-04-22, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
April 22, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00428415

PeptideScanner retained ClinicalTrials.gov record NCT00428415 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-05, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
March 5, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00481104

PeptideScanner retained ClinicalTrials.gov record NCT00481104 at 2026-11-16T17:29:46.323Z. Its registry update date was 2011-07-04, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
July 4, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02737891

PeptideScanner retained ClinicalTrials.gov record NCT02737891 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
May 14, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03149445

PeptideScanner retained ClinicalTrials.gov record NCT03149445 at 2026-11-16T17:29:46.323Z. Its registry update date was 2024-02-26, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
February 26, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03286829

PeptideScanner retained ClinicalTrials.gov record NCT03286829 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
May 14, 2020
Evidence lane
Clinical trials
Record added

Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.

PubMed lists PMID 17324246 in British journal of clinical pharmacology as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-02-23 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata
Record added

Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach.

PubMed lists PMID 17982477 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-05 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 20, 2021
Evidence lane
Literature metadata
Record added

A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.

PubMed lists PMID 19705923 in Clinical pharmacokinetics as Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 20, 2021
Evidence lane
Literature metadata
Record added

Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine.

PubMed lists PMID 42320973 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-06-19 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 3, 2026
Evidence lane
Literature metadata